Form 8-K - Current report:
SEC Accession No. 0001387131-20-004921
Filing Date
2020-05-15
Accepted
2020-05-15 17:03:10
Documents
12
Period of Report
2020-05-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_051420.htm   iXBRL 8-K 32641
  Complete submission text file 0001387131-20-004921.txt   210980

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT txmd-20200514_lab.xml EX-101.LAB 35273
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT txmd-20200514_pre.xml EX-101.PRE 23158
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT txmd-20200514.xsd EX-101.SCH 3204
13 EXTRACTED XBRL INSTANCE DOCUMENT txmd-8k_051420_htm.xml XML 3771
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 20886560
SIC: 2834 Pharmaceutical Preparations